Contract facts
UnrestrictedACQUIRE ASSAYS TO SUPPORT COVID-19 VACCINE DEVELOPMENT EFFORTS, IN RESPONSE TO BAA-18-100-SOL-00003, AREA OF INTEREST 8.4 COVID-19 IMMUNE ASSAYS(S) DEVELOPMENT AND IMPLEMENTATION. is a federal Unrestricted award for Barda - Aspr / Daappo / Barda Dcma held by Meso Scale Diagnostics LLC. Estimated value $23.2M ($23.2M obligated). Current period of performance ends Sep 28, 2026. Last award drew 1 bidder. Place of performance: ROCKVILLE MD.
ACQUIRE ASSAYS TO SUPPORT COVID-19 VACCINE DEVELOPMENT EFFORTS, IN RESPONSE TO BAA-18-100-SOL-00003, AREA OF INTEREST 8.4 COVID-19 IMMUNE ASSAYS(S) DEVELOPMENT AND IMPLEMENTATION.
Recompete timing
PublicCurrent PoP ended Sep 28, 2026 (4 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on 75A50123C00046? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordMeso Scale Diagnostics LLC — $31.3M obligated across 126 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75A50123C00046?
75A50123C00046 (Acquire ASSAYS to support) is a Barda - Aspr / Daappo / Barda Dcma award with a potential value of $23.2M, currently held by Meso Scale Diagnostics LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75A50123C00046?
Barda - Aspr / Daappo / Barda Dcma awarded 75A50123C00046 to Meso Scale Diagnostics LLC (potential $23.2M).
Who is the incumbent on 75A50123C00046?
Meso Scale Diagnostics LLC is the incumbent with $31.3M across 126 related awards in SCOUT’s public footprint. The current period of performance ends Sep 28, 2026.
When does Meso Scale Diagnostics LLC’s 75A50123C00046 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 28, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75A50123C00046? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.